{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:13:13Z","timestamp":1793823193696,"version":"4.6.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"7902","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2022,3,24]]},"DOI":"10.1038\/s41586-022-04479-6","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T11:59:30Z","timestamp":1643716770000},"page":"715-720","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":799,"title":["SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo"],"prefix":"10.1038","volume":"603","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1506-0535","authenticated-orcid":false,"given":"Kenrie P. Y.","family":"Hui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C. W.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5717-3322","authenticated-orcid":false,"given":"Man-chun","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka-chun","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel H. H.","family":"Ching","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka-ling","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonia Tong","family":"Kam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7541-4262","authenticated-orcid":false,"given":"Haogao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6289-663X","authenticated-orcid":false,"given":"Ko-Yung","family":"Sit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K. Y.","family":"Hsin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6196-7317","authenticated-orcid":false,"given":"Timmy W. K.","family":"Au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9101-7953","authenticated-orcid":false,"given":"Leo L. M.","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malik","family":"Peiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7217-7444","authenticated-orcid":false,"given":"John M.","family":"Nicholls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8174-8405","authenticated-orcid":false,"given":"Michael C. W.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,1]]},"reference":[{"key":"4479_CR1","doi-asserted-by":"publisher","unstructured":"Cele, S. et al. Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization. Nature https:\/\/doi.org\/10.1038\/s41586-021-04387-1 (2021).","DOI":"10.1038\/s41586-021-04387-1"},{"key":"4479_CR2","unstructured":"Tracking SARS-CoV-2 Variants (WHO, 2021); https:\/\/www.who.int\/en\/activities\/tracking-SARS-CoV-2-variants\/"},{"key":"4479_CR3","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1056\/NEJMcibr2032888","volume":"383","author":"RS Baric","year":"2020","unstructured":"Baric, R. S. Emergence of a highly fit SARS-CoV-2 variant. N. Engl. J. Med. 383, 2684\u20132686 (2020).","journal-title":"N. Engl. J. Med."},{"key":"4479_CR4","doi-asserted-by":"publisher","first-page":"eabg3055","DOI":"10.1126\/science.abg3055","volume":"372","author":"NG Davies","year":"2021","unstructured":"Davies, N. G. et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science 372, eabg3055 (2021).","journal-title":"Science"},{"key":"4479_CR5","doi-asserted-by":"crossref","unstructured":"Lubinski, B. et al. Functional evaluation of the P681H mutation on the proteolytic activation of the SARS-CoV-2 variant B.1.1.7 (Alpha) spike. iScience 25, 103589 (2022).","DOI":"10.1016\/j.isci.2021.103589"},{"key":"4479_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s12038-021-00145-7","volume":"46","author":"S Srivastava","year":"2021","unstructured":"Srivastava, S., Banu, S., Singh, P., Sowpati, D. T. & Mishra, R. K. SARS-CoV-2 genomics: an Indian perspective on sequencing viral variants. J. Biosci. 46, 22 (2021).","journal-title":"J. Biosci."},{"key":"4479_CR7","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1016\/j.cell.2021.02.037","volume":"184","author":"D Zhou","year":"2021","unstructured":"Zhou, D. et al. Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera. Cell 184, 2348\u20132361 (2021).","journal-title":"Cell"},{"key":"4479_CR8","doi-asserted-by":"publisher","first-page":"7045","DOI":"10.1002\/jcp.30367","volume":"236","author":"A Khan","year":"2021","unstructured":"Khan, A. et al. Higher infectivity of the SARS-CoV-2 new variants is associated with K417N\/T, E484K, and N501Y mutants: an insight from structural data. J. Cell. Physiol. 236, 7045\u20137057 (2021).","journal-title":"J. Cell. Physiol."},{"key":"4479_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21118-2","volume":"12","author":"S Ozono","year":"2021","unstructured":"Ozono, S. et al. SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity. Nat. Commun. 12, 848 (2021).","journal-title":"Nat. Commun."},{"key":"4479_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/all.15065","volume":"77","author":"G Augusto","year":"2021","unstructured":"Augusto, G. et al. In vitro data suggest that Indian Delta variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion. Allergy 77, 111\u2013117 (2021).","journal-title":"Allergy"},{"key":"4479_CR11","unstructured":"Weekly Epidemiological Update on COVID-19\u201414 December 2021 (WHO, 2021)."},{"key":"4479_CR12","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/S0140-6736(21)01358-1","volume":"397","author":"A Sheikh","year":"2021","unstructured":"Sheikh, A., McMenamin, J., Taylor, B. & Robertson, C. SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness. Lancet 397, 2461\u20132462 (2021).","journal-title":"Lancet"},{"key":"4479_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1473-3099(21)00475-8","volume":"22","author":"KA Twohig","year":"2021","unstructured":"Twohig, K. A. et al. Hospital admission and emergency care attendance risk for SARS-CoV-2 Delta (B.1.617.2) compared with Alpha (B.1.1.7) variants of concern: a cohort study. Lancet Infect. Dis. 22, 35\u201342 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"4479_CR14","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3201\/eid2802.212422","volume":"28","author":"H Gu","year":"2021","unstructured":"Gu, H. et al. Probable transmission of SARS-CoV-2 Omicron variant in quarantine hotel, Hong Kong, China, November 2021. Emerg. Infect. Dis. 28, 460\u2013462 (2021).","journal-title":"Emerg. Infect. Dis."},{"key":"4479_CR15","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41586-020-2895-3","volume":"592","author":"JA Plante","year":"2021","unstructured":"Plante, J. A. et al. Spike mutation D614G alters SARS-CoV-2 fitness. Nature 592, 116\u2013121 (2021).","journal-title":"Nature"},{"key":"4479_CR16","doi-asserted-by":"publisher","first-page":"1601710","DOI":"10.1183\/13993003.01710-2016","volume":"49","author":"KP Hui","year":"2017","unstructured":"Hui, K. P. et al. Tropism and innate host responses of influenza A\/H5N6 virus: an analysis of ex\u00a0vivo and in vitro cultures of the human respiratory tract. Eur. Respir. J. 49, 1601710 (2017).","journal-title":"Eur. Respir. J."},{"key":"4479_CR17","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S2213-2600(13)70138-3","volume":"1","author":"MC Chan","year":"2013","unstructured":"Chan, M. C. et al. Tropism and innate host responses of a novel avian influenza A H7N9 virus: an analysis of ex-vivo and in-vitro cultures of the human respiratory tract. Lancet Respir. Med. 1, 534\u2013542 (2013).","journal-title":"Lancet Respir. Med."},{"key":"4479_CR18","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S2213-2600(14)70158-4","volume":"2","author":"RW Chan","year":"2014","unstructured":"Chan, R. W. et al. Tropism and replication of Middle East respiratory syndrome coronavirus from dromedary camels in the human respiratory tract: an in-vitro and ex-vivo study. Lancet Respir. Med. 2, 813\u2013822 (2014).","journal-title":"Lancet Respir. Med."},{"key":"4479_CR19","doi-asserted-by":"publisher","first-page":"e2103984118","DOI":"10.1073\/pnas.2103984118","volume":"118","author":"Z Zhou","year":"2021","unstructured":"Zhou, Z. et al. Phenotypic and genetic characterization of MERS coronaviruses from Africa to understand their zoonotic potential. Proc. Natl Acad. Sci. USA 118, e2103984118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"4479_CR20","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1073\/pnas.1718769115","volume":"115","author":"DKW Chu","year":"2018","unstructured":"Chu, D. K. W. et al. MERS coronaviruses from camels in Africa exhibit region-dependent genetic diversity. Proc. Natl Acad. Sci. USA 115, 3144\u20133149 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"4479_CR21","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S2213-2600(20)30193-4","volume":"8","author":"KPY Hui","year":"2020","unstructured":"Hui, K. P. Y. et al. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures. Lancet Respir. Med. 8, 687\u2013695 (2020).","journal-title":"Lancet Respir. Med."},{"key":"4479_CR22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271\u2013280 (2020).","journal-title":"Cell"},{"key":"4479_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41588-020-00759-x","volume":"53","author":"C Blume","year":"2021","unstructured":"Blume, C. et al. A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection. Nat. Genet. 53, 205\u2013214 (2021).","journal-title":"Nat. Genet."},{"key":"4479_CR24","doi-asserted-by":"publisher","unstructured":"Willett, B. J. et al. The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism. Preprint at https:\/\/doi.org\/10.1101\/2022.01.03.21268111 (2022).","DOI":"10.1101\/2022.01.03.21268111"},{"key":"4479_CR25","unstructured":"SARS-CoV-2 Variants of Concern and Variants Under Investigation (UK Health Security Agency, 2021)."},{"key":"4479_CR26","doi-asserted-by":"publisher","unstructured":"Peacock, T. P. et al. The SARS-CoV-2 variant, Omicron, shows rapid replication in human primary nasal epithelial cultures and efficiently uses the endosomal route of entry. Preprint at https:\/\/doi.org\/10.1101\/2021.12.31.474653 (2022).","DOI":"10.1101\/2021.12.31.474653"},{"key":"4479_CR27","doi-asserted-by":"publisher","unstructured":"Adenaiye, O. O. et al. Infectious SARS-CoV-2 in exhaled aerosols and efficacy of masks during early mild infection. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciab797 (2021).","DOI":"10.1093\/cid\/ciab797"},{"key":"4479_CR28","doi-asserted-by":"publisher","unstructured":"Cameroni, E. et al. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. Nature https:\/\/doi.org\/10.1038\/s41586-021-04386-2 (2021).","DOI":"10.1038\/s41586-021-04386-2"},{"key":"4479_CR29","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.chom.2021.11.005","volume":"29","author":"H Wu","year":"2021","unstructured":"Wu, H. et al. Nucleocapsid mutations R203K\/G204R increase the infectivity, fitness, and virulence of SARS-CoV-2. Cell Host Microbe 29, 1788\u20131801 (2021).","journal-title":"Cell Host Microbe"},{"key":"4479_CR30","doi-asserted-by":"publisher","first-page":"100252","DOI":"10.1016\/j.lanepe.2021.100252","volume":"12","author":"H Allen","year":"2022","unstructured":"Allen, H. et al. Household transmission of COVID-19 cases associated with SARS-CoV-2 Delta variant (B.1.617.2): national case-control study. Lancet Reg. Health. Eur. 12, 100252 (2022).","journal-title":"Lancet Reg. Health. Eur."},{"key":"4479_CR31","doi-asserted-by":"publisher","unstructured":"Li, H., Liu, T., Wang, L., Wang, M. & Wang, S. SARS-CoV-2 Delta variant infects ACE2(low) primary human bronchial epithelial cells more efficiently than other variants. J. Med. Virol. https:\/\/doi.org\/10.1002\/jmv.27372 (2021).","DOI":"10.1002\/jmv.27372"},{"key":"4479_CR32","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41586-021-03944-y","volume":"599","author":"P Mlcochova","year":"2021","unstructured":"Mlcochova, P. et al. SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion. Nature 599, 114\u2013119 (2021).","journal-title":"Nature"},{"key":"4479_CR33","doi-asserted-by":"publisher","unstructured":"Liu, Y. et al. Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant. Preprint at https:\/\/doi.org\/10.1101\/2021.08.12.456173 (2021).","DOI":"10.1101\/2021.08.12.456173"},{"key":"4479_CR34","doi-asserted-by":"publisher","unstructured":"Lubinski, B. et al. Spike protein cleavage-activation mediated by the SARS-CoV-2 P681R mutation: a case-study from its first appearance in variant of interest (VOI) A.23.1 identified in Uganda. Preprint at https:\/\/doi.org\/10.1101\/2021.06.30.450632 (2021).","DOI":"10.1101\/2021.06.30.450632"},{"key":"4479_CR35","doi-asserted-by":"crossref","unstructured":"Wolter, N. et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet 399, 437\u2013446 (2022).","DOI":"10.1016\/S0140-6736(22)00017-4"},{"key":"4479_CR36","unstructured":"SARS-CoV-2 Variants of Concern and Variants Under Investigation in England Technical briefing: Update on Hospitalisation and Vaccine Effectiveness for Omicron VOC-21NOV-01 (B.1.1.529) (UK Health Security Agency, 2021)."},{"key":"4479_CR37","doi-asserted-by":"publisher","first-page":"7001","DOI":"10.1073\/pnas.2002589117","volume":"117","author":"S Matsuyama","year":"2020","unstructured":"Matsuyama, S. et al. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc. Natl Acad. Sci. USA 117, 7001\u20137003 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"4479_CR38","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S2213-2600(20)30193-4","volume":"8","author":"KPY Hui","year":"2020","unstructured":"Hui, K. P. Y. et al. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures. Lancet Respi. Med. 8, 687\u2013695 (2020).","journal-title":"Lancet Respi. Med."},{"key":"4479_CR39","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.2353\/ajpath.2010.091087","volume":"176","author":"MC Chan","year":"2010","unstructured":"Chan, M. C. et al. Tropism and innate host responses of the 2009 pandemic H1N1 influenza virus in ex vivo and in vitro cultures of human conjunctiva and respiratory tract. Am. J. Pathol. 176, 1828\u20131840 (2010).","journal-title":"Am. J. Pathol."},{"key":"4479_CR40","doi-asserted-by":"publisher","first-page":"1601710","DOI":"10.1183\/13993003.01710-2016","volume":"49","author":"KP Hui","year":"2017","unstructured":"Hui, K. P. et al. Tropism and innate host responses of influenza A\/H5N6 virus: an analysis of ex vivo and in vitro cultures of the human respiratory tract. Eur. Respir. J. 49, 1601710 (2017).","journal-title":"Eur. Respir. J."},{"key":"4479_CR41","doi-asserted-by":"publisher","unstructured":"Yen, H. L. et al. Cellular tropism of SARS-CoV-2 in the respiratory tract of Syrian hamsters and B6.Cg-Tg(K18-ACE2)2Prlmn\/J transgenic mice. Vet. Pathol. https:\/\/doi.org\/10.1177\/03009858211043084 (2021).","DOI":"10.1177\/03009858211043084"},{"key":"4479_CR42","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/BF01863914","volume":"162","author":"G K\u00e4rber","year":"1931","unstructured":"K\u00e4rber, G. Beitrag zur kollektiven behandlung pharmakologischer reihenversuche. Naunyn Schmiedebergs Arch. Exp. Pathol. Pharmakol. 162, 480\u2013483 (1931).","journal-title":"Naunyn Schmiedebergs Arch. Exp. Pathol. Pharmakol."},{"key":"4479_CR43","first-page":"e3465","volume":"9","author":"AR Crowe","year":"2019","unstructured":"Crowe, A. R. & Yue, W. Semi-quantitative determination of protein expression using immunohistochemistry staining and analysis: an integrated protocol. Bio Protoc. 9, e3465 (2019).","journal-title":"Bio Protoc."},{"key":"4479_CR44","doi-asserted-by":"publisher","first-page":"e105375","DOI":"10.1371\/journal.pone.0105375","volume":"9","author":"L Berglin","year":"2014","unstructured":"Berglin, L. et al. In situ characterization of intrahepatic non-parenchymal cells in PSC reveals phenotypic patterns associated with disease severity. PLoS ONE 9, e105375 (2014).","journal-title":"PLoS ONE"},{"key":"4479_CR45","doi-asserted-by":"publisher","first-page":"3935","DOI":"10.1128\/AAC.00389-09","volume":"53","author":"RW Chan","year":"2009","unstructured":"Chan, R. W. et al. DAS181 inhibits H5N1 influenza virus infection of human lung tissues. Antimicrob. Agents Chemother. 53, 3935\u20133941 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"4479_CR46","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1093\/infdis\/jir665","volume":"204","author":"KP Hui","year":"2011","unstructured":"Hui, K. P. et al. H5N1 influenza virus-induced mediators upregulate RIG-I in uninfected cells by paracrine effects contributing to amplified cytokine cascades. J. Infect. Dis. 204, 1866\u20131878 (2011).","journal-title":"J. Infect. Dis."},{"key":"4479_CR47","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.4049\/jimmunol.182.2.1088","volume":"182","author":"KP Hui","year":"2009","unstructured":"Hui, K. P. et al. Induction of proinflammatory cytokines in primary human macrophages by influenza A virus (H5N1) is selectively regulated by IFN regulatory factor 3 and p38 MAPK. J. Immunol. 182, 1088\u20131098 (2009).","journal-title":"J. Immunol."},{"key":"4479_CR48","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1093\/infdis\/jiab002","volume":"224","author":"CHT Bui","year":"2021","unstructured":"Bui, C. H. T. et al. Tropism of SARS-CoV-2, SARS-CoV, and influenza virus in canine tissue explants. J. Infect. Dis. 224, 821\u2013830 (2021).","journal-title":"J. Infect. Dis."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-04479-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-04479-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-04479-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T21:07:29Z","timestamp":1648069649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-04479-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":48,"journal-issue":{"issue":"7902","published-print":{"date-parts":[[2022,3,24]]}},"alternative-id":["4479"],"URL":"https:\/\/doi.org\/10.1038\/s41586-022-04479-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1189219\/v1","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,1]]},"assertion":[{"value":"13 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}